ImageneBio Inc

IMA | NASDAQ

Price Alert Chart Builder DCF Calculator

$4.88

+$0.07 (+1.46%)

Sep 22, 2026, 1:20 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Market Data

Market Cap $54.25M

Enterprise Value $-79.99M

Beta 0.71

Average Volume 21.17K

Shares Outstanding (Diluted) 16.16M

Shares Change YoY -66.51%

Institutional Ownership 47.77%

Exchange NASDAQ

ISIN US45175G2075

Price Performance

Price Change 1M -15.3%

Price Change 3M -20.0%

Price Change 6M -13.5%

Price Change YTD -28.9%

Price Change 1Y -39.9%

Price Change 3Y -91.2%

Price Change 5Y -96.9%

1M CAGR (ann.) -15.5%

1Y CAGR (ann.) -42.4%

5Y CAGR (ann.) -49.8%

All-Time CAGR -55.0%

Valuation

PE Ratio -0.92

Forward PE N/A

PEG Ratio -0.01

Forward PEG -0.12

PS Ratio N/A

Forward PS 374.90

PB Ratio 0.38

P/FCF Ratio -0.74

P/Adj. FCF Ratio -0.72

P/OCF Ratio -1.35

EV/Sales N/A

EV/EBIT 1.48

EV/EBITDA 1.51

EV/FCF 1.09

Earnings Yield -108.3%

FCF Yield -135.3%

Adj. FCF Yield -138.6%

Financial Health

Net Cash $136.15M

Total Debt $1.91M

Cash & Short-Term Investments $136.15M

Total Assets $152.05M

Current Ratio 21.47

Quick Ratio 21.47

Debt / Equity Ratio 0.01

Debt / EBITDA -0.04

Debt / FCF -0.03

OCF / Debt -38.38

Interest Coverage -614.18

Altman Z-Score 0.84

Piotroski F-Score 2

Margins & Profitability

Gross Profit Margin 0.0%

Operating Profit Margin 0.0%

EBITDA Margin 0.0%

Net Profit Margin 0.0%

FCF Margin N/A

Adj. FCF Margin N/A

SBC / Revenue 0.0%

SBC Impact (per share) -2.5%

Returns

Return on Assets -34.5%

Return on Equity -39.0%

Return on Invested Capital -39.8%

Return on Capital Employed -40.5%

Return on Tangible Assets -34.5%

Historical Growth (CAGR)

Revenue CAGR 3Y -104.6%

Revenue CAGR 5Y -74.5%

Revenue CAGR 10Y N/A

EPS CAGR 3Y -78.2%

EPS CAGR 5Y -33.0%

EPS CAGR 10Y N/A

FCF CAGR 3Y -0.4%

FCF CAGR 5Y 6.4%

FCF CAGR 10Y N/A

Analyst Forecasts

Analyst Rating Buy

Analyst Count 5

EPS Growth Next 3Y 12.2%

Revenue Growth Next 3Y N/A

Earnings Date Nov 10, 2026

EPS Estimate (next Q) -$0.83

EPS Growth Est (next Q) -71.5%

Revenue Est (next Q) N/A

Revenue Growth Est (next Q) N/A

Fair Value Estimates

Graham Number N/A

Graham Upside N/A

Lynch Fair Value N/A

Lynch Upside N/A

Price Target $1.33

Price Target Upside -72.3%

Cash Flow

Operating Cash Flow $-73.38M

Free Cash Flow $-73.38M

Adj. Free Cash Flow $-75.22M

FCF Per Share -$3.57

OCF Per Share -$3.57

OCF/S Ratio 0.0%

Income Statement

Revenue $0

Gross Profit $-735K

Operating Income $-58.96M

EBITDA $-52.8M

Net Income $-52.48M

EPS (Diluted) -$5.21

Revenue / Employee N/A

Profit / Employee $-2.92M

Employees 18